Literature DB >> 24526675

MicroRNA regulation and cardiac calcium signaling: role in cardiac disease and therapeutic potential.

Masahide Harada1, Xiaobin Luo, Toyoaki Murohara, Baofeng Yang, Dobromir Dobrev, Stanley Nattel.   

Abstract

MicroRNAs (miRNAs) are emerging as key control molecules in the regulation of gene expression, and their role in heart disease is becoming increasingly evident. Given the critical role of Ca(2+) handling and signaling proteins in the maintenance of cardiac function, the targeting of such proteins by miRNAs would be expected to have important consequences. miRNAs have indeed been shown to control the expression of genes encoding important Ca(2+) handling and signaling proteins, and are themselves regulated by Ca(2+)-dependent processes. Ca(2+)-related miRNAs have been found to be significant pathophysiological contributors in conditions like myocardial ischemic injury, cardiac hypertrophy, heart failure, ventricular arrhythmogenesis, and atrial fibrillation. This review is a comprehensive analysis of the present knowledge concerning miRNA regulation of Ca(2+) handling processes, the participation of Ca(2+)-regulating miRNAs in the evolution of heart disease, the mutual relationship between Ca(2+) signaling and miRNAs in the control of cardiac function, and the potential value of miRNA-control of Ca(2+) handling as a therapeutic target.

Entities:  

Keywords:  gene expression; microRNA

Mesh:

Substances:

Year:  2014        PMID: 24526675     DOI: 10.1161/CIRCRESAHA.114.301798

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  42 in total

1.  Ca2+ signaling as a mechanism of haloperidol-induced cytotoxicity in human astrocytes and assessing the protective role of a Ca2+ chelator.

Authors:  Shu-Shong Hsu; Wei-Zhe Liang
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-06-27       Impact factor: 3.000

2.  LncRNA-uc.40 silence promotes P19 embryonic cells differentiation to cardiomyocyte via the PBX1 gene.

Authors:  Rongqiang Wu; Peng Xue; Yu Wan; Shizhong Wang; Meng Gu
Journal:  In Vitro Cell Dev Biol Anim       Date:  2018-08-15       Impact factor: 2.416

Review 3.  Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.

Authors:  Rui Guo; Sreejayan Nair
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-03-24       Impact factor: 5.187

Review 4.  Electrophysiological and molecular mechanisms of paroxysmal atrial fibrillation.

Authors:  Stanley Nattel; Dobromir Dobrev
Journal:  Nat Rev Cardiol       Date:  2016-08-04       Impact factor: 32.419

5.  Knockdown of Plakophilin 2 Downregulates miR-184 Through CpG Hypermethylation and Suppression of the E2F1 Pathway and Leads to Enhanced Adipogenesis In Vitro.

Authors:  Priyatansh Gurha; Xiaofan Chen; Raffaella Lombardi; James T Willerson; Ali J Marian
Journal:  Circ Res       Date:  2016-07-28       Impact factor: 17.367

6.  Age-dependent increase in c-Jun N-terminal kinase-2 activity: does this help to understand Ca2+-calmodulin-dependent protein-kinase II-mediated atrial arrhythmogenesis in human atrial fibrillation?

Authors:  Dobromir Dobrev; Kristina Lorenz
Journal:  Cardiovasc Res       Date:  2018-04-01       Impact factor: 10.787

7.  Association between miR-181b and PKG 1 in myocardial hypertrophy and its clinical implications.

Authors:  Wei Zhong; Jun Yang; Qian Cao; Xiaodong Huan
Journal:  Exp Ther Med       Date:  2015-07-20       Impact factor: 2.447

Review 8.  MicroRNAs and atrial fibrillation: mechanisms and translational potential.

Authors:  Xiaobin Luo; Baofeng Yang; Stanley Nattel
Journal:  Nat Rev Cardiol       Date:  2014-11-25       Impact factor: 32.419

9.  Trim65: a cofactor for regulation of the microRNA pathway.

Authors:  Shitao Li; Lingyan Wang; Bishi Fu; Martin E Dorf
Journal:  RNA Biol       Date:  2014       Impact factor: 4.652

10.  SCN5A: the greatest HITS collection.

Authors:  David S Park; Glenn I Fishman
Journal:  J Clin Invest       Date:  2018-02-19       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.